Leaflet thrombosis in transcatheter and surgical bioprosthetic aortic valves Dr. Raj R. Makkar and Dr. C. Michael Gibson Discuss

Silent cerebral microbleeds during TAVR Dr. Eric Van Belle and Dr. Serge Korjian Discuss

Intersection of coronary artery disease and TAVR Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

State of the art in trans-septal therapies Dr. Zoltan Turi, Dr. George Hanzel and Dr. C. Michael Gibson Discuss

Pediatric VSD: What is it? Dr. Evan Zahn and Dr. C. Michael Gibson Discuss

State of the art in PFO Dr. John Carroll and Dr. C. Michael Gibson Discuss

Highlights from the CHD Track Dr. Henri Justino, Dr. Dennis Kim and Dr. C. Michael Gibson Discuss

Protection of the brain during open heart surgery by LAAO Dr. Helena Domínguez and Dr. Rim Halaby Discuss

Gender Differences in Outcomes With TAVR Women Undergoing TAVR are at a Decreased Risk of Long-term Mortality

In a recent meta-analysis published in the Journal of the American College of Cardiology, it was found that postoperative complications of Transcatheter Aortic Valve Replacement (TAVR) were different between males and females. While females were at increased risk of short-term complications (within 30 days) such as bleeding, stroke, and vascular complications, they had a lower incidence all-cause mortality within one year of the procedure. Continue reading →